Find a Clinical Trial
Filter
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Period Kits
Autism, Menstruation
All genders
0-17
Recruiting now
Department of Obstetrics + Gynecology
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
LIPP
Obesity, Pregnancy
Female
18-45
Recruiting now
Department of Obstetrics + Gynecology